OC
CLX icon

Oppenheimer & Co’s Clorox CLX Stock Holding History

Oppenheimer & Co’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.31M Buy
22,334
+7,188
+47% +$815K 0.03% 546
2025
Q4 		$1.53M Buy
15,146
+440
+3% +$47.8K 0.02% 626
2025
Q3 		$1.81M Sell
14,706
-1,511
-9% -$188K 0.02% 640
2025
Q2 		$1.95M Sell
16,217
-1,205
-7% -$161K 0.03% 583
2025
Q1 		$2.57M Buy
17,422
+493
+3% +$75.3K 0.04% 476
2024
Q4 		$2.75M Sell
16,929
-381
-2% -$62.3K 0.04% 461
2024
Q3 		$2.82M Buy
17,310
+268
+2% +$39.7K 0.04% 438
2024
Q2 		$2.33M Buy
17,042
+659
+4% +$91.5K 0.04% 487
2024
Q1 		$2.51M Buy
16,383
+1,224
+8% +$183K 0.04% 448
2023
Q4 		$2.16M Buy
15,159
+607
+4% +$80.9K 0.04% 475
2023
Q3 		$1.91M Sell
14,552
-5,997
-29% -$911K 0.04% 478
2023
Q2 		$3.27M Buy
20,549
+5,033
+32% +$812K 0.07% 326
2023
Q1 		$2.46M Buy
15,516
+526
+4% +$78.9K 0.05% 396
2022
Q4 		$2.1M Sell
14,990
-3,772
-20% -$535K 0.05% 429
2022
Q3 		$2.41M Sell
18,762
-319
-2% -$46K 0.06% 376
2022
Q2 		$2.69M Buy
19,081
+75
+0.4% +$10.7K 0.06% 375
2022
Q1 		$2.64M Buy
19,006
+207
+1% +$31.7K 0.05% 431
2021
Q4 		$3.28M Buy
18,799
+776
+4% +$129K 0.06% 373
2021
Q3 		$2.98M Buy
18,023
+573
+3% +$98.7K 0.06% 385
2021
Q2 		$3.14M Sell
17,450
-750
-4% -$137K 0.06% 383
2021
Q1 		$3.51M Sell
18,200
-251
-1% -$48.3K 0.07% 325
2020
Q4 		$3.73M Sell
18,451
-3,340
-15% -$691K 0.08% 289
2020
Q3 		$4.58M Sell
21,791
-1,642
-7% -$366K 0.11% 204
2020
Q2 		$5.14M Buy
23,433
+1,119
+5% +$224K 0.13% 168
2020
Q1 		$3.87M Buy
22,314
+5,113
+30% +$845K 0.12% 188
2019
Q4 		$2.64M Buy
17,201
+371
+2% +$55.4K 0.07% 332
2019
Q3 		$2.56M Buy
16,830
+141
+0.8% +$22.3K 0.07% 328
2019
Q2 		$2.56M Buy
16,689
+250
+2% +$38.2K 0.07% 327
2019
Q1 		$2.64M Buy
16,439
+1,254
+8% +$195K 0.07% 329
2018
Q4 		$2.34M Sell
15,185
-1,117
-7% -$174K 0.07% 304
2018
Q3 		$2.45M Buy
16,302
+1,415
+10% +$201K 0.06% 335
2018
Q2 		$2.01M Buy
14,887
+504
+4% +$62.2K 0.05% 390
2018
Q1 		$1.92M Buy
14,383
+1,073
+8% +$144K 0.05% 402
2017
Q4 		$1.98M Buy
13,310
+1,912
+17% +$260K 0.05% 393
2017
Q3 		$1.5M Buy
11,398
+304
+3% +$40.8K 0.04% 466
2017
Q2 		$1.48M Sell
11,094
-664
-6% -$89.6K 0.04% 473
2017
Q1 		$1.58M Sell
11,758
-396
-3% -$51.3K 0.04% 447
2016
Q4 		$1.46M Sell
12,154
-1,060
-8% -$125K 0.04% 455
2016
Q3 		$1.65M Sell
13,214
-911
-6% -$119K 0.05% 432
2016
Q2 		$1.96M Buy
14,125
+1,237
+10% +$160K 0.06% 373
2016
Q1 		$1.62M Buy
12,888
+3,943
+44% +$501K 0.05% 409
2015
Q4 		$1.13M Sell
8,945
-2,021
-18% -$251K 0.03% 515
2015
Q3 		$1.27M Sell
10,966
-976
-8% -$110K 0.04% 502
2015
Q2 		$1.24M Sell
11,942
-337
-3% -$36.4K 0.03% 560
2015
Q1 		$1.35M Sell
12,279
-4,393
-26% -$477K 0.04% 529
2014
Q4 		$1.74M Sell
16,672
-600
-3% -$60K 0.05% 436
2014
Q3 		$1.66M Buy
17,272
+3,115
+22% +$282K 0.05% 439
2014
Q2 		$1.29M Buy
14,157
+4,542
+47% +$407K 0.04% 523
2014
Q1 		$846K Sell
9,615
-4,756
-33% -$418K 0.03% 661
2013
Q4 		$1.33M Buy
14,371
+5,775
+67% +$520K 0.04% 469
2013
Q3 		$703K Sell
8,596
-184
-2% -$15.5K 0.02% 647
2013
Q2 		$730K Buy
+8,780
New +$755K 0.03% 600

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Oppenheimer & Co's CLX Position: Q1 2026 in Review

Oppenheimer & Co increased its Clorox (CLX) stake by 47% in Q1 2026, buying an estimated $815K and bringing the position to 22,334 shares worth $2.31M. The position accounts for 0.03% of the portfolio, ranked #546.

Oppenheimer & Co first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.14M in Q2 2020. 1,082 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Oppenheimer & Co held 22,334 shares of Clorox worth $2.31M as of Q1 2026.
  • Oppenheimer & Co bought 7,188 Clorox shares in Q1 2026, an estimated $815K.
  • Clorox made up 0.03% of Oppenheimer & Co's portfolio in Q1 2026, its #546 holding.
  • Oppenheimer & Co first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
  • Oppenheimer & Co's Clorox position peaked at $5.14M in Q2 2020.
  • 1,082 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.